Icahn School Of Medicine At Mount Sinai
Prognosis after PCI affected by interaction of chronic kidney disease, diabetes in women
Concomitant chronic kidney disease and diabetes was prognostic of all-cause death and MI within 3 years among women undergoing drug-eluting stent implantation, according to new data.
Mobility intervention for hospitalized patients with cancer has ‘remarkable’ impact
An early mobility program for hospitalized patients with cancer yielded a reduction in hospital readmissions and improvements in mobility and functional status, according to a study conducted at Icahn School of Medicine at Mount Sinai.
Gestational diabetes greatly increases risk for developing future incident diabetes
Women who have gestational diabetes during pregnancy have a more than 11 times higher risk for developing diabetes than women who did not have gestational diabetes, according to a study published in Diabetes Care.
Plant-centered diet consumption linked to less lung function decline
WASHINGTON — Annual lung function decline rates were lower in individuals who had high adherence to a plant-centered diet, according to an abstract presented at the American Thoracic Society International Conference.
New models enable deeper research into acute myeloid leukemia
Researchers at Tisch Cancer Center have created innovative models of acute myeloid leukemia, offering an unprecedented resource for studying this deadly blood cancer, according to a study published in Blood Cancer Discovery.
NALIRIFOX extends OS, PFS for certain patients with pancreatic cancer
CHICAGO — First-line NALIRIFOX significantly extended in OS and PFS vs. gemcitabine and nab-paclitaxel among patients with treatment-naive metastatic pancreatic ductal adenocarcinoma, according to a study presented at ASCO Annual Meeting.
Tumor mutational burden associated with survival on immunotherapy across cancer types
CHICAGO — Higher tumor mutational burden appeared associated with more favorable real-world OS among a large cohort of patients with various cancer types who used immune checkpoint inhibitor monotherapy.
Despite evidence of durability, belantamab mafodotin misses endpoint for multiple myeloma
CHICAGO — Belantamab mafodotin monotherapy did not significantly extend PFS compared with the combination of pomalidomide and dexamethasone among adults with relapsed or refractory multiple myeloma, phase 3 study results showed.
ESC guideline may help risk stratify patients with non ST-elevation ACS undergoing PCI
The 2020 European Society of Cardiology guidelines for the management of non ST-elevation ACS may help clinicians determine the thrombotic risk categories of patients being considered for PCI, a speaker reported.
Antibiotics during chemotherapy may benefit some patients with pancreatic cancer
Perichemotherapy antibiotics appeared associated with longer survival among patients with metastatic pancreatic ductal adenocarcinoma treated with gemcitabine, according to retrospective study results.